About NDA Group AB
NDA is a world-leading regulatory and drug development company, with 25 years of excellence, an extensive portfolio of services, and more than 1600 clients. Over the last three years, NDA Group has supported a quarter of the new medicinal products approved in the US and Europe.
Our dedicated team of over 150 consultants combined with the unique NDA Advisory Board provide drug developers with unmatched regulatory expertise, ensuring the safe development of complex & innovative treatments that meet the rigorous requirements of the regulatory agencies.
We are a genuine part of our client’s story, and we are a true regulatory partner with one goal in mind, to benefit our client, and ultimately, the patient.
|
|
|
51-200 employees
View all NDA Group AB employees
|
|
Pharmaceuticals
|
|
Johanneslundsvägen 2, Upplands Väsby, Sweden 19461, SE
|
|
1997
|
|
Pharmacovigilance, Consultancy, Quality Assurance, Strategic Advice, Regulatory Affairs, Drug Development, Health Technology Assessment (Hta)
|
NDA Group AB Alternatives
Frequently Asked Questions about NDA Group AB
Johan Stromquist is the CEO of NDA Group AB. To contact Johan Stromquist email at [email protected]. Or you may call +46 70 911 96 40
NDA Group AB Staff Directory
Search NDA Group AB Staff Directory
Find accurate personal emails, work emails and phone numbers for employees
Supercharge your
Prospecting &
Outreach with
ContactOut
Supercharge your Prospecting &
Outreach with ContactOut
Find countless prospects outside of LinkedIn fast
Accelerate prospecting with instant access to 300M professionals from 30M companies with the right contact details.
